Long-acting amylin receptor agonist developed by Novo Nordisk, researched for appetite regulation and weight management alongside semaglutide (CagriSema).
Peptigrity tracks Cagrilintide across 219 shops with 161 independent lab tests and an average HPLC purity of 99.64%.
Long-acting amylin receptor agonist developed by Novo Nordisk, researched for appetite regulation and weight management alongside semaglutide (CagriSema).
Every submitted test helps the community verify purity across brands. Free, fast, independent.